Acclarent ENT Portfolio
Ear, Nose and Throat Surgical Interventions
ApprovedCommercial
Key Facts
Indication
Ear, Nose and Throat Surgical Interventions
Phase
Approved
Status
Commercial
Company
About Integra LifeSciences
Integra LifeSciences is a publicly traded global leader in medical technologies, with a core mission of restoring lives through impactful innovation in neurosurgery and tissue reconstruction. The company has built a highly differentiated portfolio through strategic acquisitions, including Codman® Neurosurgery and Acclarent, establishing itself as the global leader in neurosurgical products. Under the leadership of President & CEO Mojdeh Poul, Integra is focused on strengthening its quality systems, advancing its innovation pipeline, and executing a transformation to drive long-term growth and value.
View full company profile